KREBSBIO.BO

Krebs Biochemicals & Industries Limited is an Indian enterprise primarily involved in the manufacturing and marketing of active pharmaceutical ingredients (APIs). The company also dedicates resources to advancing biotechnological processes that find applications in medical, agricultural, and industrial sectors. Its product portfolio includes compounds such as androstenedione, lovastatin, and simvastatin, which are crucial for anti-cholesterol treatments and serve as steroid intermediates. Furthermore, Krebs is engaged in the development of a diverse array of other pharmaceutical substances, including amlodipine and telmisartan for addressing hypertension, cetirizine for anti-allergic purposes, orlistat for weight management, serratiopeptidase for its anti-inflammatory effects, and phenylephrine for tackling cold and cough symptoms. Beyond its own product lines, the firm provides contract manufacturing solutions for prominent pharmaceutical companies and global corporations. Established in 1991, the company's main operations are based out of Hyderabad, India.